← FDA Drug Approvals (Drugs@FDA)
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON PHARMA INC · Approved 2022-04-05
Drug application
- FDA Application #
ANDA208473- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Generic name
- Linagliptin
- Active ingredients
- LINAGLIPTIN; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- PRINSTON PHARMA INC
- First approval
- 2022-04-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown